230 related articles for article (PubMed ID: 38799337)
1. Targeting Metabolic Syndrome Pathways: Carrot microRNAs As Potential Modulators.
Reza-Zaldívar EE; Jacobo-Velázquez DA
ACS Omega; 2024 May; 9(20):21891-21903. PubMed ID: 38799337
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
3. Oxymatrine and insulin resistance: Focusing on mechanistic intricacies involve in diabetes associated cardiomyopathy via SIRT1/AMPK and TGF-β signaling pathway.
Seksaria S; Mehan S; Dutta BJ; Gupta GD; Ganti SS; Singh A
J Biochem Mol Toxicol; 2023 May; 37(5):e23330. PubMed ID: 36890713
[TBL] [Abstract][Full Text] [Related]
4. The role of microRNAs in the regulation of insulin signaling pathway with respect to metabolic and mitogenic cascades: A review.
Ebrahimi R; Bahiraee A; Niazpour F; Emamgholipour S; Meshkani R
J Cell Biochem; 2019 Dec; 120(12):19290-19309. PubMed ID: 31364207
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7.
Zhou QY; Yang HM; Liu JX; Xu N; Li J; Shen LP; Zhang YZ; Koda S; Zhang BB; Yu Q; Chen JX; Zheng KY; Yan C
Parasit Vectors; 2021 Sep; 14(1):472. PubMed ID: 34521449
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer.
Heyn GS; Corrêa LH; Magalhães KG
Front Endocrinol (Lausanne); 2020; 11():563816. PubMed ID: 33123088
[TBL] [Abstract][Full Text] [Related]
7. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
Hagymási K; Reismann P; Rácz K; Tulassay Z
Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
[TBL] [Abstract][Full Text] [Related]
8. Ileal interposition surgery targets the hepatic TGF-β pathway, influencing gluconeogenesis and mitochondrial bioenergetics in the UCD-T2DM rat model of diabetes.
Hung C; Napoli E; Ross-Inta C; Graham J; Flores-Torres AL; Stanhope KL; Froment P; Havel PJ; Giulivi C
FASEB J; 2019 Oct; 33(10):11270-11283. PubMed ID: 31307210
[TBL] [Abstract][Full Text] [Related]
9. Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease.
Matsuda S; Kobayashi M; Kitagishi Y
ISRN Endocrinol; 2013; 2013():472432. PubMed ID: 23431468
[TBL] [Abstract][Full Text] [Related]
10. The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature.
Huang HYR; Badar S; Said M; Shah S; Bharadwaj HR; Ramamoorthy K; Alrawashdeh MM; Haroon F; Basit J; Saeed S; Aji N; Tse G; Roy P; Bardhan M
Mol Biol Rep; 2024 Apr; 51(1):493. PubMed ID: 38580818
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases.
Pérez-García A; Torrecilla-Parra M; Fernández-de Frutos M; Martín-Martín Y; Pardo-Marqués V; Ramírez CM
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204710
[TBL] [Abstract][Full Text] [Related]
12. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
[TBL] [Abstract][Full Text] [Related]
13. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.
Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C
Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes.
Nigi L; Grieco GE; Ventriglia G; Brusco N; Mancarella F; Formichi C; Dotta F; Sebastiani G
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469501
[TBL] [Abstract][Full Text] [Related]
15. Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis.
Mahmoudi A; Butler AE; Jamialahmadi T; Sahebkar A
Biomed Res Int; 2021; 2021():3654660. PubMed ID: 34988225
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix remodeling and TGF-β1/Smad signaling in diabetic colon mucosa.
D'Arpino MC; Fuchs AG; Sánchez SS; Honoré SM
Cell Biol Int; 2018 Apr; 42(4):443-456. PubMed ID: 29227005
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
[TBL] [Abstract][Full Text] [Related]
18. Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease.
Sookoian S; Pirola CJ
PLoS One; 2013; 8(3):e58895. PubMed ID: 23516571
[TBL] [Abstract][Full Text] [Related]
19. The Role of TGF-β/SMAD Signaling in Hepatocellular Carcinoma: from Mechanism to Therapy and Prognosis.
Xin X; Cheng X; Zeng F; Xu Q; Hou L
Int J Biol Sci; 2024; 20(4):1436-1451. PubMed ID: 38385079
[TBL] [Abstract][Full Text] [Related]
20. [Nonalcoholic fatty liver disease : Hepatic manifestations of metabolic syndrome].
Roeb E
Inn Med (Heidelb); 2023 Apr; 64(4):323-328. PubMed ID: 36580094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
